Company News

Share this article:

Sanofi-Aventis is buying out Merck's 50% stake in the companies' joint animal health venture, Merial Limited, for $4 billion in cash. Following completion of the deal, Sanofi will own 100% of Merial. However, Merck will pick up an animal health business – Intervet – with its acquisition of Schering-Plough, and the companies have signed a call option that would allow Sanofi to combine Merial with Intervet after the Merck/Schering-Plough acquisition has been completed.

Covance secured a $145 million dollar deal with Merck to provide genomic analysis services, and will acquire Merck's Gene Expression Laboratory in Seattle. Covance expects to offer employment “to the majority of current employees” at the lab, and will move into the site on August 17, according to a company release.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.